Wednesday, October 22, 2014

Click below to purchase eBooks. 
Use Code NJ2014 for NJSHP.

Member Benefits
  • Continuing Education Opportunities
  • Professional Advocacy
  • Networking Opportunities  
  • Learn More...

ASHP Health-System Pharmacy News

Wed, 22 Oct 2014 00:00:00 -0400

The decade-old concept of combination therapy packaged in a so-called polypill for patients with cardiovascular disease received a mostly favorable reception in September from FDA officials and agency advisers.

Mon, 20 Oct 2014 00:00:00 -0400

FDA last week approved the marketing of nintedanib, or Ofev, for the treatment of idiopathic pulmonary fibrosis.

Fri, 17 Oct 2014 00:00:00 -0400

Before their hospital became the first to report what evolved into a nationwide outbreak of severe enterovirus D-68 (EV-D68) infections, the pharmacy staff at Children's Mercy Hospital and Clinics in Kansas City, Missouri, noticed some unexpected things happening with their drug inventory.

Thu, 16 Oct 2014 00:00:00 -0400

FDA on October 15 approved the marketing of pirfenidone, or Esbriet, for the treatment of idiopathic pulmonary fibrosis.

Tue, 14 Oct 2014 00:00:00 -0400

Gilead Sciences on October 10 announced the approval of Harvoni, a two-drug combination product for the treatment of chronic hepatitis C virus (HCV) genotype 1 infection in adults.

Home   |   Membership   |   Chapters   |   Councils   |   Events   |   Resources   |   Employment   |   About Us
Copyright 2012 by NJSHP